We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current THRD market cap is 157.7M. The company's latest EPS is USD -0.6841 and P/E is -5.10.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.85M | -10.41M | -11.29M | -14.07M | -17.07M |
| Net Income | -7.34M | -6.84M | -7.86M | -10.71M | -13.8M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -11.12M | -19M | -37.71M | -43.95M |
| Net Income | -12.81M | -29.61M | -35.16M | -30.82M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 282.25M | 277.71M | 270.52M | 265.86M | 304.49M |
| Total Liabilities | 9.29M | 8.63M | 7.02M | 9.14M | 9.64M |
| Total Equity | 272.96M | 269.09M | 263.5M | 256.71M | 294.85M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.43M | 129.16M | 298.68M | 277.71M |
| Total Liabilities | 8.09M | 5.69M | 9.61M | 8.63M |
| Total Equity | -18.36M | -46.71M | 289.07M | 269.09M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -14.82M | -20.43M | -6.29M | -15.1M | -23.27M |
| Investing | -168k | -169k | N/A | N/A | N/A |
| Financing | 1,000 | 799k | 49k | 1.36M | 50.3M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.19M | -15.75M | -34.92M | -20.43M |
| Investing | N/A | N/A | -36k | -169k |
| Financing | 10.83M | 135.75M | 195.99M | 799k |
| Market Cap | 157.7M |
| Price to Earnings Ratio | -5.10 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.58 |
| Price to Book Ratio | 0.58 |
| Dividend Yield | - |
| Shares Outstanding | 45.06M |
| Average Volume (1 week) | 360.3k |
| Average Volume (1 Month) | 357.14k |
| 52 Week Change | -61.20% |
| 52 Week High | 16.94 |
| 52 Week Low | 3.18 |
| Spread (Intraday) | 0.18 (5%) |
| Company Name | Third Harmonic Bio Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.thirdharmonicbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
